Core Insights - Humana Inc. (HUM) benefits from a strong care delivery model focused on value-based care, increasing premiums, strategic acquisitions, an aging population in the U.S., and solid cash generation capacity [1] - HUM's shares have declined 36.4% over the past year, while the industry has fallen 43.4% [1] Company Overview - Humana is headquartered in Louisville, KY, with a market capitalization of $20.7 billion, offering health insurance benefits through various plans and specialty products [2] - The company currently holds a Zacks Rank 3 (Hold) due to solid prospects [2] Financial Estimates - The Zacks Consensus Estimate for Humana's 2026 earnings is $9.70 per share, with revenues projected at $160.8 billion, indicating a 23.9% year-over-year rise [3] - Humana has beaten earnings estimates in three of the past four quarters, with an average surprise of 7% [3] Growth Drivers - Growth is driven by robust expansion in the Medicare Advantage business, with approximately 3,586,100 members (68%) in value-based relationships as of Dec. 31, 2025 [4] - Premiums grew 9.6% year-over-year in 2025, supported by increasing membership [4] - The company is focusing on a sustainable, member-centric model, prioritizing pricing discipline and long-term margins [5] Operational Strategy - Humana operates through two main divisions: CenterWell and Insurance, with a focus on enhancing primary care, pharmacy, and home health services [6] - The Insurance segment's adjusted revenues rose 10% year-over-year in 2025, while CenterWell's adjusted revenues grew by 12.7% [6] - Strategic acquisitions, such as the recent acquisition of MaxHealth, are enhancing growth and value-based care capabilities [7] Financial Position - As of Dec. 31, 2025, Humana had cash, cash equivalents, and investment securities totaling $19.9 billion, with a history of returning excess capital to shareholders [8] - In 2025, the company bought back shares worth $151 million and paid a dividend of $430 million, with a remaining share repurchase capacity of $2.7 billion as of Feb. 18, 2026 [8] Key Concerns - Humana faces rising medical costs, with total operating expenses as a percentage of total revenues reaching 97.9% in 2025, indicating limited operating leverage [12] - Long-term debt increased by 11% from the previous year, leading to higher interest expenses that may pressure margins [13] - The forward P/E ratio of 15.63X is higher than the industry average of 12.99X, indicating potential valuation concerns [13]

Core Insights - Humana Inc. (HUM) is positioned for growth due to increasing premiums, strategic acquisitions, an aging population in the U.S., and strong cash generation capacity [1] Membership and Premium Growth - Humana's membership base is expanding, particularly in Medicare Advantage and state-based programs, with Group Medicare Advantage membership increasing by 4.6% year over year and state-based contracts rising by 13.7% in Q2 2025 [2] - Premiums have shown consistent growth, with increases of 9.9% in 2022, 15.5% in 2023, 10.7% in 2024, and 8.6% in the first half of 2025 [2] - An anticipated increase of 175,000-250,000 members in state-based contracts is expected in 2025 [2] Segment Performance and Revenue Projections - Adjusted revenues in the insurance segment grew by 8.4% year over year in the first half of 2025, with projected revenues of at least $123 billion for the segment in 2025 [3] - The CenterWell segment's revenues increased by 8.9% year over year, with expectations of reaching at least $21.5 billion in 2025 [4] Strategic Expansion and Acquisitions - Humana is expanding its Medicaid presence with a new contract in Virginia, bringing its active presence to 10 states, with three additional states pending [5] - The company is pursuing strategic acquisitions and optimizing its portfolio by divesting non-core operations to enhance profitability [5] Financial Position - As of June 30, 2025, Humana held cash, cash equivalents, and investment securities totaling $21.7 billion, significantly exceeding its long-term debt of $12.6 billion [6] - The company has engaged in share repurchases worth $109 million in the first half of 2025, supported by strong operating cash flows [6] Earnings Performance - Humana has a strong earnings surprise history, exceeding estimates in three of the last four quarters with an average surprise of 9.6% [9] Challenges and Concerns - Operating expenses have been increasing, with year-over-year jumps of 11.5%, 14.9%, 12.5%, and 7.8% from 2022 to the first half of 2025 [10] - The benefit ratio deteriorated by 70 basis points year over year to 89.7% in Q2 2025, with expectations for the insurance segment's benefit ratio to be between 90.1% and 90.5% for 2025 [10] - Humana's debt-laden balance sheet is leading to increased interest expenses, which may pressure margins [10] Competitive Landscape - Competitors like Elevance Health, Inc. and The Cigna Group are also performing well, with Elevance Health's total operating revenues rising by 14.8% year over year in the first half of 2025 [11] - Cigna's adjusted revenues increased by 13% year over year in the same period, indicating strong market competition [12]